DMNOMORE has a total of 11 patent applications. Its first patent ever was published in 2013. It filed its patents most often in United States, Australia and New Zealand. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are ORBAN BIOTECH LLC, ARIUS RES INC and PROMIS NEUROSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 2 | |
#3 | New Zealand | 2 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Analysing materials | |
#3 | Peptides | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Orban Tihamer | 11 |
Publication | Filing date | Title |
---|---|---|
NZ733023A | Ctla4 fusion proteins for the treatment of diabetes. | |
NZ733351A | Combinations of modalities for the treatment of diabetes |